Previous 10 | Next 10 |
2024-01-11 08:29:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a previous column, I noted that each political party has sectors of the economy that they tend to support more than the opposing party. Furthermore, when Republicans and Democrats are in...
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received a No Objection Letter from Health Canada to conduct a Phase II trial for LSALT peptide, targeting...
2024-01-07 07:09:29 ET More on Materials Select Sector SPDR ETF XLB: Materials Dashboard For December XLB: The ETF That Beat The S&P 500 XLB: S&P500 Materials ETF rises in 2023, CE, MLM, ECL among top movers Materials Sector Weekly Round-up: Cabot at ...
TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received approval in Turkey from the Ministry of Health to proceed with a Phase II trial for LSALT peptide...
TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Kocaeli University Clinical Research Ethics Committee to proceed with a P...
TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that its Board of Directors has granted a total of 350,000 stock options to directors and officers pursuant to the Com...
TORONTO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has submitted a Clinical Trial Application to Health Canada to obtain permission to proceed with a Phase II trial f...
A Chinese state planner says the country will set up a backup production system for coal production to secure China’s coal supply and stabilize prices despite national plans to begin phasing out coal use in the latter half of the decade. China is one of dozens of countries that pledged t...
2023-12-05 15:13:14 ET Summary Arch Resources has seen a strong performance lately due to a rebound in coking coal prices. Q3 financials were slightly weaker compared to Q2, but improvements are expected in Q4 and 2024. The stock is attractively priced, with the free cash flow...
2023-11-22 01:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Arch Coal Inc. Class A Company Name:
ARCH Stock Symbol:
NYSE Market:
Arch Coal Inc. Class A Website:
Arch Resources to Announce Second Quarter 2024 Results on July 25 PR Newswire ST. LOUIS , July 11, 2024 /PRNewswire/ -- Arch Resources, Inc. (NYSE: ARCH) will discuss its second quarter 2024 financial results in an investor conference call on Thursday, July 25,...
The consumption of energy globally in 2023 increased greatly, with crude oil and coal pushing fossil-fuel emissions to new heights. The consumption of coal in India stood at 21.93 exajoules, which equals about 748 million tons of coal equivalent (Mtce). This figure was significantly greater t...
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP) glass vial filling stage for cilast...